Table 2. Baseline clinical characteristics (n = 180).
| Group A (n=60) | Group B (n=60) | Group C (n=60) | |
|---|---|---|---|
| Age (mean ± SDe) | 52.2 ± 9.83 | 50.7 ± 11.23 | 54.27 ± 12.21 |
| Male (%) | 68.33 | 78.33 | 73.33 |
| Female (%) | 31.66 | 21.66 | 26.66 |
| Type of examination | |||
| Hepatic angiography (%) | 8 (13.33%) | 5 (8.33%) | 9 (10.5%) |
| TFCAa (%) | 25 (41.66%) | 22 (36.66%) | 27 (45%) |
| TACEb (%) | 17 (28.33%) | 16 (26.66%) | 17 (28.33%) |
| Femoral angiography (%) | 10 (16.66%) | 4 (6.66%) | 3 (5%) |
| Coronary angiography (%) | 10 (16.66%) | 13 (21.66%) | 14 (23.33%) |
| Blood level (g/dL) | |||
| Hbc | 13.32 ± 3.27 | 14.27 ± 4.98 | 14.25 ± 4.77 |
| Pltd | 183.28 ± 23.75 | 176.78 ± 31.25 | 191 ± 24.65 |
TFCAa, tramsfemoral cerebral angiography; TACEb, transcatheter arterial chemoembolization; Hbc, hemoglobin; Pltd, platelet; SDe, standard deviation